Will you have Appetite decreased with Idiopathic pulmonary fibrosis - from FDA reports

Summary

Appetite decreased is found among people with Idiopathic pulmonary fibrosis, especially for people who are male, 60+ old, take medication Esbriet and have High blood pressure. This study is created by eHealthMe based on reports of 2,408 people who have Idiopathic pulmonary fibrosis from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on Appetite decreased and Idiopathic pulmonary fibrosis, and their synonyms.

What is Idiopathic pulmonary fibrosis?

Idiopathic pulmonary fibrosis (chronic lung disease) can be treated by Azathioprine, Prednisone (latest reports from 35,782 Idiopathic pulmonary fibrosis patients)

What is Appetite decreased?

Appetite decreased (decreased appetite occurs when you have a reduced desire to eat) has been reported by people with type 2 diabetes, high blood pressure, hepatitis c, pain, depression (latest reports from 140,554 Appetite decreased patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 19, 2019

2,408 people who have Idiopathic Pulmonary Fibrosis and Appetite Decreased are studied.


Number of reports submitted per year:

Would you have Appetite decreased when you have Idiopathic pulmonary fibrosis?

Gender of people who have Idiopathic Pulmonary Fibrosis and experience Appetite Decreased *:

  • female: 33.66 %
  • male: 66.34 %

Age of people who have Idiopathic Pulmonary Fibrosis and experience Appetite Decreased *:

  • 0-1: 0.14 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.14 %
  • 40-49: 0.34 %
  • 50-59: 3.2800000000000002 %
  • 60+: 96.1 %

Top co-existing conditions for these people *:

  1. High Blood Pressure: 83 people, 3.45%
  2. High Blood Cholesterol: 72 people, 2.99%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 58 people, 2.41%
  4. Interstitial Lung Disease: 31 people, 1.29%
  5. Diabetes: 30 people, 1.25%
  6. Preventive Health Care: 28 people, 1.16%
  7. Depression: 25 people, 1.04%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 24 people, 1.00%
  9. Cough: 24 people, 1.00%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 19 people, 0.79%

Most common drugs for these people *:

  1. Esbriet: 1,652 people, 68.60%
  2. Ofev: 601 people, 24.96%
  3. Metformin: 120 people, 4.98%
  4. Pantoprazole: 104 people, 4.32%
  5. Lipitor: 84 people, 3.49%
  6. Synthroid: 77 people, 3.20%
  7. Amlodipine: 70 people, 2.91%
  8. Lasix: 68 people, 2.82%
  9. Spiriva: 66 people, 2.74%
  10. Vitamin B12: 63 people, 2.62%

Top symptoms for these people *:

  1. Weight Decreased: 941 people, 39.08%
  2. Nausea (feeling of having an urge to vomit): 891 people, 37.00%
  3. Fatigue (feeling of tiredness): 781 people, 32.43%
  4. Diarrhea: 741 people, 30.77%
  5. Breathing Difficulty: 548 people, 22.76%
  6. Weakness: 454 people, 18.85%
  7. Cough: 417 people, 17.32%
  8. Dizziness: 353 people, 14.66%
  9. Abdominal Discomfort: 304 people, 12.62%
  10. Nausea And Vomiting: 274 people, 11.38%

* Approximation only. Some reports may have incomplete information.



Do you have Appetite decreased with Idiopathic pulmonary fibrosis?

You are not alone:




Related studies

Drugs that are associated with Appetite decreased
Appetite decreased (3,360 drugs)
Other conditions that could cause Appetite decreased
Appetite decreased (3,659 conditions)
Browse all symptoms of Idiopathic pulmonary fibrosis
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you have Appetite decreased and Idiopathic pulmonary fibrosis



Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.